PRF Technologies (PRFX) Net Income Growth (1y) (2021 - 2024)
PRF Technologies (PRFX) Net Income Growth (1y) (2021 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn | 68.18% |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | -0.17% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -384.49% |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | -14.68% |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | 105.80% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 2,405.06% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -14.93% |
| 10 | PRF Technologies | 709,530.45 | -3.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 178.28% |
| Mar 31, 2024 | -338.56% |
| Dec 31, 2023 | -21.01% |
| Sep 30, 2023 | -98.29% |
| Jun 30, 2023 | -230.44% |
| Mar 31, 2023 | 236.25% |
| Dec 31, 2022 | -28.75% |
| Sep 30, 2022 | 219.09% |
| Jun 30, 2022 | 406.35% |
| Mar 31, 2022 | 17.00% |
| Dec 31, 2021 | -65.42% |
| Sep 30, 2021 | -262.63% |
| Jun 30, 2021 | -152.19% |
| Mar 31, 2021 | -57.48% |